Attitudes and perceptions towards substances among people with mental disorders: A systematic review

Acta Psychiatrica Scandinavica

Volumn 126, Issue 2, 2012, Pages 87-105

  Thornton, L K ^a   Baker, A L ^a   Johnson, M P ^a   Lewin, T J ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Alcohol drinking; Cannabis; Mental disorders; Review; Tobacco

Indexed keywords

ALCOHOL CONSUMPTION; HUMAN; LEISURE; MENTAL DISEASE; MENTAL PATIENT; MOOD DISORDER; PATIENT ATTITUDE; PLEASURE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SMOKING; SOCIAL ASPECT; SUBSTANCE ABUSE; SYSTEMATIC REVIEW;

ALCOHOLIC BEVERAGES; ALCOHOLISM; ATTITUDE TO HEALTH; CANNABIS; HUMANS; MARIJUANA ABUSE; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS; TOBACCO; TOBACCO USE DISORDER;

EID: 84863596421     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2012.01861.x     Document Type: Review

References (49)

1. Dengenhardt L, Hall W, Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 2001;96:1603-1614.
2. Carey MP, Carey KB, Meisler AW. Psychiatric symptoms in mentally ill chemical abusers. J Nerv Mental Dis 1991;179:136-138.
3. Healey C, Peters S, Kinderman P, Mccracken C, Morriss R. Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: a qualitative study. J Affect Disorders 2009;113:118-126.
4. Ziedonis D, Nickou C. Substance abuse in patients with schizophrenia. In: Hwang MY, Bermanzohn PC, eds. Schizophrenia and comorbid conditions: Diagnosis and treatment. Washington: American Psychiatric Press, 2001:187-222.
5. Maniglio R. Severe mental illness and criminal victimization: a systematic review. Acta Psychiatr Scan 2009;119:180-191.
6. Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 2001;31:659-668.
7. Jenkins R, Lewis G, Bebbington P et al. The National Psychiatric Morbidity surveys of Great Britain - initial findings from the household survey. Psychol Med 1997;27:775-789.
8. Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518.
9. Dickey B, Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care. Am J Public Health 1996;86:973-977.
10. Drake RE, O'neal EL, Wallach MA. A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008;34:123-138.
11. Drake RE, Mueser KT, Brunnette MF, Mchugo GJ. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J 2004;27:360-374.
12. Cleary M, Hunt GE, Matheson SL, Siegfried N, Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2008;1:CD001088.
13. Baker A, Turner A, Kay-Lambkin F, Lewin T. The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders. Addict Behav 2009;34:852.
14. Chabrol H, Duconge E, Casas C, Roura C, Carey KB. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav 2005;30:829-840.
15. Spencer C, Castle D, Michie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophrenia Bull 2002;28:233-247.
16. Clark G, Scott N, Cook S. Formative research with young Australians to assist in the development of the National Illicit Drugs Campaign. Canberra: Commonwealth Department of Health and Ageing, 2003.
17. Roy A, Wibberley C, Lamb J. The usual suspects: alcohol, tobacco and other drug use in 15-16-year-old school pupils - prevalence, feelings and perceived health risks. Drug- Educ Prev Polic 2005;12:305-315.
18. Bertram S, Flaherty B, Everingham S. Knowledge and use of alcohol and other drugs among Vietnamese-speaking migrants. Drug Alcohol Rev 1996;15:121-126.
19. Jukic A, Pino N, Flaherty B. Alcohol and other drug use, attitudes and knowledge amongst italian-speakers in Sydney. Sydney: Drug and Alcohol Directorate NSW Health Department, 1997.
20. Gregg L, Barrowclough C, Haddock G. Reasons for increased substance use in psychosis. Clin Psychol Rev 2007;27:494-510.
21. Wells GA, Shea B, O'connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis, 2008. Available from: [cited 2011 21 July].
22. Warner R, Taylor D, Wright JD et al. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am J Orthopsychiat 1994;64:30-39.
23. Baker A, Clancy C, Carr VJ et al. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiat Scand 2002;106:233-240.
24. Forchuk C, Norman R, Malla A et al. Schizophrenia and the motivation for smoking. Perspect Psychiatr Care 2002;38:41-49.
25. Fowler IL, Carr V, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bull 1998;24:443-455.
26. Golafshani N. Understanding reliability and validity in qualitative research. Qualitative Report 2003;8:597-607.
27. Abrams K, Kushner MG. The moderating effects of tension-reduction alcohol outcome expectancies on placebo responding in individuals with social phobia. Addict Behav 2004;29:1221-1224.
28. Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997;96:329-333.
29. Baker A, Richmond RL, Haile M et al. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiat Res 2007;150:141-152.
30. Barr AM, Procyshyn RM, Hui P, Johnson JL, Honer WG. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophrenia Res 2008;100:252-260.
31. Boyd MR, Baliko B, Cox MF, Tavakoli A. Stress, coping, and alcohol expectancies in rural african-american women. Arch Psychiat Nurs 2007;21:70-79.
32. Buckner JD, Schmidt NB. Social anxiety disorder and marijuana use problems: the mediating role of marijuana effect expectancies. Depress Anxiety 2009;26:864-870.
33. Currie SR, Hodgin DC, El-Guebaly N, Campbell W. Influence of depression and gender on smoking expectancies and temptations in alcoholics in early recovery. J Subst Abuse 2001;13:443-458.
34. Goswami S, Mattoo SK, Basu D, Singh G. Substance-abusing schizophrenics: do they self-medicate? Am J Addict 2004;13:139-150.
35. Green B, Kavanagh DJ, Young RM. Reasons for cannabis use in men with and without psychosis. Drug Alcohol Rev 2004;23:445-453.
36. Green B, Kavanagh DJ, Young RM. Predictors of cannabis use in men with and without psychosis. Addict Behav 2007;32:2879-2887.
37. Gerpegui M, Martinez-Ortega JM, Jurado D, Aguilar MC, Diaz FJ, De Leon J. Subjective effects and the main reason for smoking in outpatients with schizophrenia: a case-control study. Compr Psychiat 2007;48:186-191.
38. Nishith P, Mueser KT, Srsic C, Beck AT. Expectations and Motives for Alcohol Use in a Psychiatric Outpatient Population. J Nerv Ment Dis 1997;185:622-626.
39. Pencer A, Addington J. Reasons for using substances in adolescents with and without psychosis. Early Intervent Psychiat 2008;2:42-44.
40. Schaub M, Fanghaenel K, Stohler R. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. Aust NZ J Psychiat 2008;42:1060-1065.
41. Schofield D, Tennant C, Nash L et al. Reasons for cannabis use in psychosis. Aust NZ J Psychiat 2006;40:570-574.
42. Waldrop AE, Back SE, Verduin ML, Brady KT. Triggers for cocaine and alcohol use in the presence and absence of posttraumatic stress disorder. Addict Behav 2007;32:634-639.
43. Peralta V, Cuesta M. Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiat Res 1994;53:31-40.
44. Thornton L, Baker A, Johnson MP, Lewin T. Reasons for substance use among people with psychotic disorders: method triangulation approach. Psychol Addict Behav. 2011;26:279-288.
45. Thornton LK, Baker AL, Lewin T et al. Reasons for substance use among people with mental disorders. Addict Behav. 2011;37:427-434.
46. Smith SY, Curbow B, Stillman FA. Harm perception of nicotine products in college freshmen. Nicotine Tob Res 2007;9:977-982.
47. Denzin NK, Lincoln YS. The discipline and practice of qualitative research. In: Denzin NK, Lincoln YS, eds. Strategies of qualitative inquiry, 2nd edn. Thousand Oaks: Sage, 2003:1-45.
48. Shanahan P, Elliott D. Evaluation of the effectiveness of the graphic health warnings on tobacco product packaging 2008. Canberra: Australian Government Department of Health and Ageing, 2009.
49. Australian Institute of Health and Welfare. Drugs in Australia 2010: tobacco, alcohol and other drugs. Canberra: AIHW, 2011.